- Home
- CGNT vs AUTL Comparison
CGNT vs AUTL Comparison
Compare CGNT & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGNT
- AUTL
- Stock Information
- Founded
- CGNT 2020
- AUTL 2014
- Country
- CGNT Israel
- AUTL United Kingdom
- Employees
- CGNT N/A
- AUTL N/A
- Industry
- CGNT Computer Software: Prepackaged Software
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CGNT Technology
- AUTL Health Care
- Exchange
- CGNT Nasdaq
- AUTL Nasdaq
- Market Cap
- CGNT 639.4M
- AUTL 609.4M
- IPO Year
- CGNT N/A
- AUTL 2018
- Fundamental
- Price
- CGNT $9.66
- AUTL $2.22
- Analyst Decision
- CGNT Hold
- AUTL Strong Buy
- Analyst Count
- CGNT 3
- AUTL 3
- Target Price
- CGNT $8.25
- AUTL $10.20
- AVG Volume (30 Days)
- CGNT 271.0K
- AUTL 1.4M
- Earning Date
- CGNT 12-11-2024
- AUTL 03-13-2025
- Dividend Yield
- CGNT N/A
- AUTL N/A
- EPS Growth
- CGNT N/A
- AUTL N/A
- EPS
- CGNT N/A
- AUTL N/A
- Revenue
- CGNT $339,818,000.00
- AUTL $10,091,000.00
- Revenue This Year
- CGNT $13.67
- AUTL $851.83
- Revenue Next Year
- CGNT $6.92
- AUTL $264.18
- P/E Ratio
- CGNT N/A
- AUTL N/A
- Revenue Growth
- CGNT 12.16
- AUTL 82.71
- 52 Week Low
- CGNT $5.68
- AUTL $2.07
- 52 Week High
- CGNT $9.97
- AUTL $7.37
- Technical
- Relative Strength Index (RSI)
- CGNT 66.71
- AUTL 38.18
- Support Level
- CGNT $8.47
- AUTL $2.18
- Resistance Level
- CGNT $9.97
- AUTL $2.38
- Average True Range (ATR)
- CGNT 0.32
- AUTL 0.16
- MACD
- CGNT 0.06
- AUTL 0.01
- Stochastic Oscillator
- CGNT 79.33
- AUTL 7.94
About CGNT Cognyte Software Ltd.
Cognyte Software Ltd provides security analytics software that empowers governments and enterprises with Actionable Intelligence. Its interface software is designed to help customers accelerate and improve the effectiveness of investigations and decision-making.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.